Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0149-2918(02)85005-6PMID 11833836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toxicity of Quinolones

  2012cited by this paper
• Initial Clinical Experience with Clinafloxacin in the Treatment of Serious Infections

  2012cited by this paper
• Mechanisms of Fluoroquinolone Resistance: An Update 1994–1998

  2012cited by this paper
• Mode of Action of Fluoroquinolones

  2012cited by this paper
• Fluoroquinolone Treatment of Skin and Skin Structure Infections

  2012cited by this paper
• Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue Infections

  2001cited by this paper
• Clinical aspects of antimicrobial resistance.

  2000cited by this paper
• Economic justification of antimicrobial management programs: implications of antimicrobial resistance.

  2000cited by this paper
• Appropriate prescribing of oral beta-lactam antibiotics.

  2000cited by this paper
• Expanded activity and utility of the new fluoroquinolones: A review

  1999cited by this paper
• Emerging nosocomial infections and antimicrobial resistance.

  1999cited by this paper
• Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).

  1999cited by this paper
• The fluoroquinolones.

  1999cited by this paper
• Expanded activity and utility of the new fluoroquinolones: a review.

  1999cited by this paper
• Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Pathogens Associated with Skin and Soft Tissue Infections During 1997 from an International Surveillance Programme

  1999cited by this paper
• Infectious diseases.

  1998cited by this paper
• General principles of antimicrobial therapy.

  1998cited by this paper
• Conventional and genetic laboratory tests used to guide antimicrobial therapy.

  1998cited by this paper
• Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

  1998cited by this paper
• In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin.

  1997cited by this paper
• Current aspects of bacterial infections of the skin.

  1997cited by this paper
• Piperacillin/Tazobactam: A New Beta-Lactam/Beta-Lactamase Inhibitor Combination

  1995cited by this paper
• Treatment of skin and soft-tissue infections.

  1995cited by this paper
• Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.

  1994cited by this paper
• Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.

  1993cited by this paper
• Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.

  1993cited by this paper

• The Epidemiology of Antibiotic-Related Adverse Events in the Treatment of Diabetic Foot Infections: A Narrative Review of the Literature

  2023cites this paper
• Identification of Persister Drug Combination Clinafloxacin + Cefuroxime + Gentamicin That Eradicates Persistent Pseudomonas aeruginosa Infection in a Murine Cystic Fibrosis Model

  2022cites this paper
• Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.

  2019cites this paper
• RANKING OF MAJOR CLASSES OF ANTIBIOTICS FOR ACTIVITY AGAINST STATIONARY PHASE GRAM-NEGATIVE BACTERIA PSEUDOMONAS AERUGINOSA AND CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE AND IDENTIFICATION OF DRUG COMBINATIONS THAT ERADICATE THEIR PERSISTENT INFECTIONS

  2019cites this paper
• Ranking of Major Classes of Antibiotics for Activity against Stationary Phase Pseudomonas aeruginosa and Identification of Clinafloxacin + Cefuroxime + Gentamicin Drug Combination that Eradicates Persistent P. aeruginosa Infection in a Murine Cystic Fibrosis Model

  2019cites this paper
• Drug‐induced phototoxicity: A systematic review

  2018cites this paper
• Systemic antibiotics for treating diabetic foot infections.

  2015cites this paper
• In vitro activity and rodent efficacy of clinafloxacin for bovine and swine respiratory disease

  2013cites this paper
• Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.

  2013cites this paper
• Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.

  2012cites this paper
• Treatment of Complicated Skin and Soft Tissue Infections

  2009cites this paper
• Concentrations of piperacillin-tazobactam in human jaw and hip bone.

  2008cites this paper
• Foot infections in diabetes (DFIs) in the out‐patient setting: an Italian multicentre observational survey

  2008cites this paper
• Miscellaneous antibacterial drugs

  2007cites this paper
• An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.

  2007cites this paper
• Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.

  2007cites this paper
• Diagnosis and Treatment of Diabetic Foot Infections

  2006cites this paper
• A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.

  2006cites this paper
• Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI)

  2006cites this paper
• Efficacy of Tigecycline in Complicated Skin and Skin Structure Infections and Complicated Intra-abdominal Infections

  2005cites this paper
• Second-line Treatment of Limb-Threatening Diabetic Foot Infections with Intravenous Fosfomycin

  2005cites this paper
• New method of classifying infections in critically ill patients*

  2004cites this paper
• Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.

  2004cites this paper
• Diagnosis and treatment of diabetic foot infections.

  2004cites this paper
• Diagnosis and treatment of diabetic foot infections.

  1999cites this paper